Impax Escapes Investors' Drug Price-Fixing Suit, For Now
A California federal judge on Friday dismissed a shareholder suit alleging generic-drug maker Impax Laboratories Inc. failed to disclose to investors a federal investigation over possibly collusive market activity, but also...To view the full article, register now.
Already a subscriber? Click here to view full article